Navigation Links
Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development

CHAPEL HILL, N.C., March 1, 2013 /PRNewswire/ -- While medical science liaisons have been around for more than 40 years, the role and activities of these medical specialists have grown quickly over the last decade. The pharmaceutical industry has long relied on medical science liaisons to forge relationships with key opinion leaders (KOLs) who can provide critical insights into the market and competition.

But the changing regulatory and access environment has altered the landscape for creating and maintaining KOL and physician relationships.

To help organizations navigate this new KOL landscape, research and consulting leader Best Practices LLC published a MSL-focused report that highlights their key pre- and post-launch activities, and service frequencies. The 78-page report presents 2011 data compared to 2009 on an array of critical activities that provide insights into how MSLs can build strong, productive relationships with KOLs and physicians. 

"Roles, Resourcing and Management of Medical Science Liaisons" provides MSL leaders with key metrics to help them create and maintain an effective MSL group. The comparative structure of the report (2011 data vs. 2009 data) also opens a window to emerging trends that will enable leaders in medical affairs – the group where MSL operations are typically housed - to set a clear direction for their MSL group going forward.

For instance, the study shows companies in 2011 were having managers oversee a greater number of MSLs than they did in 2009. In 2011, 57 percent of respondents preferred to have one manager overseeing 7-10 specialists. In 2009, the preferred span-of-control was one manger to up to six specialists (47 percent).

The key topics covered in this report include:

  • Benchmark Pre and Post-Launch Service Activities
  • Identify Drivers of Group Size & Focus
  • Gain insight into Structuring & Aligning Medical With Sales Organizations
  • Identify Optimal Call Frequencies and Service Levels with Thought Leaders
  • Identify Relationship Management Standards of Excellence
  • Value Associated with MSL
  • Budget Allocation to MSLs

The research project included observations and insights from 27 leaders with 24 companies, including 10 of the Top 20 pharma organizations. To learn more about this report, download a complimentary excerpt at

Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.

SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Study Shows Cannabis Effects on Driving Skills
2. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
3. University Hospitals Case Medical Center Presents Study On The Elimination Of Retained Surgical Sponges
4. MD+DI, the Global MedTech Authority, Publishes One-of-a-Kind Study with ITG Market Research on the Medical Device Outsourcing Landscape
5. New Direct-to-Consumer Prescription Delivery Channel Mitigates Risk of Medication Non-Adherence Highlighted in JAMA Internal Medicine Study
6. KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting
7. Study Shows Medicare Savings When Local Pharmacies Fill 90-Day Prescriptions
8. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-CRP Rx In Patients With Atrial Fibrillation
9. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
10. First U.S. Patients Treated in PneumRx RENEW Pivotal Study for Treatment of Severe Emphysema
11. New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Post Your Comments:
(Date:11/26/2015)... 2015 Research and Markets ( ) has ... Market Outlook to 2019 - Rise in Cardiac Disorders and ... report to their offering. Boston ... scientific and others. --> The ... Boston scientific and others. ...
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... Global Cell Surface Testing Market: Supplier ... to their offering.  --> ... of the  "2016 Future Horizons and ...
(Date:11/26/2015)... November 26, 2015 ... addition of the  "2016 Future Horizons ... Therapeutic Drug Monitoring (TDM) Market: Supplier ... Emerging Opportunities"  report to their offering.  ... announced the addition of the  "2016 ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... ProSidebar: Fashion is a set of ... With ProSidebar: Fasion, video editors can easily add an informative sidebar to any FCPX ... Utilize presets featuring self-animating drop zones, lines, bars, and text with the ease ...
(Date:11/27/2015)... ... 2015 , ... A simply groundbreaking television series, "Voices in America", which is ... an array of issues that are presently affecting Americans. Dedicated to providing the world ... is changing the subjects consumers focus on, one episode at a time. , ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... and prominent nonprofit healthcare organizations in the country. They have overseen financial turnarounds, ... and helped advance the healthcare industry as a whole through their advocacy and ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity ... have come together on Thanksgiving Day to share the things that they are ... the Serenity Point YouTube channel, patients displayed what they wrote on index cards, ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
Breaking Medicine News(10 mins):